Accendra Health Inc (ACH) · Insider trading
What Accendra Health's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$0
0 insiders
Net, 12 months
$0
bought less sold
Latest filing
2026-10-06
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Coliseum Capital Partners, L.P.10% owner | $42.85M | – | 12 | 2025-08-14 | – |
| Leon Jonathan AEVP, Chief Financial Officer | – | $62,433 | 1 | 2024-11-21 | 130,822 |
| Sarkar SnehashishOther | – | $25,194 | 1 | 2024-11-18 | 55,886 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2025-08-14 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 492,852 | 5.31 | $2.62M | 13,100,807 | Form 4 |
| 2025-08-13 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 325,000 | 5.46 | $1.77M | 12,607,955 | Form 4 |
| 2025-08-12 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 720,000 | 5.15 | $3.71M | 12,282,955 | Form 4 |
| 2025-04-10 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 80,000 | 7.19 | $575,200 | 11,562,955 | Form 4 |
| 2025-04-09 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 225,000 | 7.39 | $1.66M | 11,482,955 | Form 4 |
| 2025-04-08 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 105,000 | 7.96 | $835,800 | 11,257,955 | Form 4 |
| 2025-04-07 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 240,000 | 7.84 | $1.88M | 11,152,955 | Form 4 |
| 2025-04-04 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 128,356 | 8.14 | $1.04M | 10,912,955 | Form 4 |
| 2025-04-03 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 160,000 | 8.53 | $1.36M | 10,784,599 | Form 4 |
| 2025-03-04 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 800,000 | 9.75 | $7.80M | 10,624,599 | Form 4 |
| 2025-03-03 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 354,901 | 9.19 | $3.26M | 9,824,599 | Form 4 |
| 2025-02-28 | Coliseum Capital Partners, L.P.10% ownerwith Coliseum Capital, LLC, Coliseum Capital Management, LLC, Shackelton Christopher S, Gray Adam | Buyindirect | 1,738,511 | 9.39 | $16.32M | 9,469,698 | Form 4 |
| 2024-11-21 | Leon Jonathan AEVP, Chief Financial Officer | Saleplan | 5,282 | 11.82 | $62,433 | 130,822 | Form 4 |
| 2024-11-18 | Sarkar SnehashishOther | Saleplan | 2,055 | 12.26 | $25,194 | 55,886 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
28 × shares withheld for tax23 × grant or award1 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-10-05 | Gardner-Smith KennethDirector, President & CEO | Grant or award A | +283,554 | – | 369,667 | Form 4 |
| 2026-09-23 | Leon Jonathan AEVP & CFO | Shares withheld for tax F | −4,265 | 0.85 | 286,268 | Form 4 |
| 2026-05-18 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax F | −1,822 | 2.91 | 166,306 | Form 4 |
| 2026-05-15 | Bernocchi Perry AEVP, Chief Operating Officer | Shares withheld for tax F | −7,908 | 3.04 | 313,913 | Form 4 |
| 2026-05-15 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax F | −966 | 3.04 | 168,128 | Form 4 |
| 2026-05-15 | Pesicka Edward ADirector, President & CEO | Shares withheld for tax F | −17,692 | 3.04 | 1,072,785 | Form 4 |
| 2026-05-15 | Leon Jonathan AEVP & CFO | Shares withheld for tax F | −1,770 | 3.04 | 290,533 | Form 4 |
| 2026-05-14 | Beck Mark ADirector | Grant or award A | +31,191 | – | 71,259 | Form 4 |
| 2026-05-14 | Gardner-Smith KennethDirector | Grant or award A | +31,191 | – | 86,113 | Form 4 |
| 2026-05-14 | Klemash Stephen WDirector | Grant or award A | +31,191 | – | 90,242 | Form 4 |
| 2026-05-14 | Kline Teresa L.Director | Grant or award A | +31,191 | – | 85,316 | Form 4 |
| 2026-03-20 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax F | −9,347 | 2.03 | 169,094 | Form 4 |
| 2026-03-20 | Bernocchi Perry AEVP, Chief Operating Officer | Shares withheld for tax F | −20,841 | 2.03 | 321,821 | Form 4 |
| 2026-03-20 | Leon Jonathan AEVP & CFO | Shares withheld for tax F | −11,286 | 2.03 | 292,303 | Form 4 |
| 2026-03-20 | Pesicka Edward ADirector, President & CEO | Shares withheld for tax F | −58,945 | 2.03 | 1,090,477 | Form 4 |
| 2026-03-09 | Galloway Heath HEVP,General Counsel & CorpSecy | Grant or award A | +61,437 | – | 178,441 | Form 4 |
| 2026-03-09 | Leon Jonathan AEVP & CFO | Grant or award A | +85,067 | – | 303,589 | Form 4 |
| 2026-03-09 | Bernocchi Perry AEVP, Chief Operating Officer | Grant or award A | +108,696 | – | 342,662 | Form 4 |
| 2025-11-19 | Long Andrew GEVP, CEO P&HS | Gift G | −47,908 | – | 214,064 | Form 4 |
| 2025-09-23 | Leon Jonathan AEVP & CFO | Shares withheld for tax F | −4,265 | 5.40 | 218,522 | Form 4 |
| 2025-06-03 | Stone Jennifer AEVP, CHRO | Shares withheld for tax F | −5,764 | 6.35 | 110,327 | Form 4 |
| 2025-05-19 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax F | −1,768 | 7.38 | 117,044 | Form 4 |
| 2025-05-15 | Bernocchi Perry AEVP, CEO,. Patient Direct | Shares withheld for tax F | −13,394 | 7.00 | 233,966 | Form 4 |
| 2025-05-15 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax F | −1,315 | 7.00 | 118,772 | Form 4 |
| 2025-05-15 | Leon Jonathan AEVP & CFO | Shares withheld for tax F | −2,641 | 7.00 | 222,787 | Form 4 |
| 2025-05-15 | Long Andrew GEVP, CEO P&HS | Shares withheld for tax F | −19,081 | 7.00 | 261,972 | Form 4 |
| 2025-05-15 | Lowry Michael WayneSVP, Corporate Controller | Shares withheld for tax F | −1,533 | 7.00 | 121,921 | Form 4 |
| 2025-05-15 | Pesicka Edward ADirector, President & CEO | Shares withheld for tax F | −35,208 | 7.00 | 1,149,422 | Form 4 |
| 2025-05-15 | Sarkar SnehashishOther | Shares withheld for tax F | −4,336 | 7.00 | 108,586 | Form 4 |
| 2025-05-15 | Beck Mark ADirector | Grant or award A | +28,914 | – | 40,068 | Form 4 |
| 2025-05-15 | Johnson-Mills RitaDirector | Grant or award A | +28,914 | – | 54,125 | Form 4 |
| 2025-05-15 | Klemash Stephen WDirector | Grant or award A | +28,914 | – | 59,051 | Form 4 |
| 2025-05-15 | Gardner-Smith KennethDirector | Grant or award A | +28,914 | – | 54,922 | Form 4 |
| 2025-05-15 | Henkel Robert JDirector | Grant or award A | +28,914 | – | 77,412 | Form 4 |
| 2025-05-15 | Kline Teresa L.Director | Grant or award A | +28,914 | – | 54,125 | Form 4 |
| 2025-05-15 | Rollins CarissaDirector | Grant or award A | +28,914 | – | 53,902 | Form 4 |
| 2025-03-20 | Sarkar SnehashishOther | Shares withheld for tax F | −1,977 | 10.09 | 112,922 | Form 4 |
| 2025-03-20 | Pesicka Edward ADirector, President & CEO | Shares withheld for tax F | −14,715 | 10.09 | 1,184,630 | Form 4 |
| 2025-03-20 | Lowry Michael WayneSVP, Corporate Controller | Shares withheld for tax F | −1,059 | 10.09 | 123,454 | Form 4 |
| 2025-03-20 | Long Andrew GEVP, CEO P&HS | Shares withheld for tax F | −4,578 | 10.09 | 281,053 | Form 4 |
| 2025-03-20 | Leon Jonathan AEVP & CFO | Shares withheld for tax F | −1,961 | 10.09 | 225,428 | Form 4 |
| 2025-03-20 | Bernocchi Perry AEVP, CEO,. Patient Direct | Shares withheld for tax F | −5,551 | 10.09 | 247,360 | Form 4 |
| 2025-03-20 | Galloway Heath HEVP,General Counsel & CorpSecy | Shares withheld for tax F | −2,734 | 10.09 | 120,087 | Form 4 |
| 2025-03-03 | Stone Jennifer AEVP, CHRO | Grant or award A | +59,013 | – | 116,091 | Form 4 |
| 2025-03-03 | Sarkar SnehashishOther | Grant or award A | +59,013 | – | 114,899 | Form 4 |
| 2025-03-03 | Pesicka Edward ADirector, President & CEO | Grant or award A | +445,279 | – | 1,199,345 | Form 4 |
| 2025-03-03 | Long Andrew GEVP, CEO P&HS | Grant or award A | +134,121 | – | 285,631 | Form 4 |
| 2025-03-03 | Leon Jonathan AEVP, Chief Financial Officer | Grant or award A | +134,121 | – | 285,631 | Form 4 |
| 2025-03-03 | Bernocchi Perry AEVP, CEO,. Patient Direct | Grant or award A | +123,391 | – | 252,911 | Form 4 |
| 2025-03-03 | Lowry Michael WayneSVP, Corporate Controller | Grant or award A | +28,166 | – | 124,513 | Form 4 |
| 2025-03-03 | Galloway Heath HEVP,General Counsel & CorpSecy | Grant or award A | +69,743 | – | 122,821 | Form 4 |
| 2024-11-15 | Sarkar SnehashishOther | Shares withheld for tax F | −1,196 | 12.27 | 57,941 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.